Security key
03969K108
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)
CUSIP: 03969K108
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 71,600,840
- Total 13F value
- $787,595,702
- Share change
- +5,799,339
- Put/Call ratio
- 34%
- SEC-reported price per share
- $11.00
- Number of holders
- 141
- Value change
- +$44,255,428
- Number of buys
- 87
- Number of sells
- 51
- Shares outstanding
- 123,454,843
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q1 2023
Institutions
141
Top holders
10
ARQT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Ownership snapshot
Top reported holders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Largest current holder
FMR LLC
13D/G signal
—
Evidence rows
15
Latest as of
31 Dec 2022
13F
3/4/5
Lead comparable stake: 7.4%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 7.4%.
Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
FMR LLC
7.4%
Frazier Life Sciences Management,...
7%
BlackRock Finance, Inc.
4.2%
STATE STREET CORP
3%
Bain Capital Life Sciences Invest...
2.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
7.4%
|
$135,259,760
9,139,173 shares
|
— | 31 Dec 2022 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
7%
|
$128,526,634
8,684,232 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.2%
|
$77,171,020
5,214,258 shares
|
— | 31 Dec 2022 |
| STATE STREET CORP |
13F
Company
|
3%
|
$54,454,898
3,679,385 shares
|
— | 31 Dec 2022 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
2.4%
|
$44,400,000
3,000,000 shares
|
— | 31 Dec 2022 |
| Rubric Capital Management LP |
13F
Company
|
2.2%
|
$40,589,281
2,742,519 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
141
Shares
71,600,840
Rows available
141
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
138
Q1 2023 holders
141
Holder diff
3
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend